GRANISETRON KABI (Fresenius Kabi Australia Pty Ltd)
Product name
GRANISETRON KABI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
26 working days (255)
Active ingredients
granisetron hydrochloride
Registration type
EOI
Indication
Generic medicine
GRANISETRON KABI is now also indicated for the prevention and treatment of post-operative nausea and vomiting in adults only.